Books.org participates in affiliate programs including Bookshop.org and the Amazon Services LLC Associates Program. We may earn a commission from qualifying purchases made through links on this page, at no additional cost to you.
Overview
The value of Age-Related Macular Degeneration has clearly stood the test of time, but progress in both basic and clinical ophthalmology has been relentless, thereby mandating the need for an updated book.
The physicians, scientists, and patients who read this Third Edition will be reassured that this markedly enhanced edition has met the challenge of providing new information that is both intellectually and clinically valuable. Dr. Lim has again chosen expert authors for the important topics in this stimulating compendium.
Chapters are devoted to the following: pathophysiology and epidemiology of age-related macular degeneration (AMD), clinical features of AMD, imaging techniques, and medical therapy for both non-neovascular AMD and neovascular AMD. Both clinically validated and experimental therapies are well described, including rehabilitation technology (a highly important topic that is often overlooked in the management of patients with AMD).
Key features of this new edition:
•Over 200 clinical photographs and illustrations (many in full colour)
•An in-depth review and analysis of the management of dry and wet AMD (medical and surgical therapies)
•Research advancements that have resulted in novel therapies
•Strategies to prevent the progression of non-exudative AMD
•Summary of studies and results from current clinical trials
•A collaboration of world renowned experts in the field with over 75 contributors
13 new chapters include:
•New genetics and treatment chapter will cover the responses of different variants to treatment.
•Oxidative Stress is moving along quickly as a new target for therapy. This is important in the pathophysiology for AMD and CNV (choroidal neovascularization—a common symptom of wet AMD).
•Polypoidal and RAP chapters are included as more info. Warrants separate chapters of these variants of AMD.
•How to analyze OCT will cover the analysis software and other programs that help in managing patients.
•Microperimetry and psychophysical testing will cover new ways to track geographic atrophy progression (includes newly uncovered data).
•Non-VEGF pathways will cover complement paths, nicotinic, etc.—important new treatment paths.
•Radiation and Steroid chapters will address new treatments that help in CNV management.
•Retinal stem cells will cover new information and potential avenues of future treatment.
•Combination therapy
Synopsis
The value of Age-Related Macular Degeneration has stood the test of time, but progress in both basic and clinical ophthalmology has been relentless, mandating the need for an updated book. This second edition focuses on the pathophysiology and the epidemiology of age-related macular degeneration (AMD), the clinical features and management of dry and wet AMD, imaging techniques, and medical therapy for both non-neovascular AMD and neovascular AMD. It describes both clinically validated and experimental therapies as well as rehabilitation technology, and presents strategies to prevent the progression of non-exudative AMD. Results from current clinical trials are also included.
New chapters in this edition cover:
Editorials
From the Publisher
"Professor Lim has brought us up to the moment. We owe her and her collaborators a vote of thanks and a vote of confidence. Hopefully, the march of time, with its inexorable acquisition of new knowledge, will mandate the need for yet another edition. For the time being, however, this Third Edition of Age-Related Macular Degeneration does its job commendably and effectively." Morton F. Goldberg, M.D., Director Emeritus The Wilmer Eye Institute, Johns Hopkins Hospital, Baltimore, Maryland USA